Neurocrine Biosciences, Inc. is a California-based (1992) and Delaware-incorporated (1996) drug company aimed at discovering, developing, and future marketing of medications for neurological and endocrine-related diseases and disorders. The company currently has eight programs in various stages of research and development, five of which are in clinical development. The product pipeline with their respective indications is as follows:
1. Clinical Development
a. GnRH Antagonist – endometriosis and benign prostatic hyperplasia
b. CRF1 Antagonsit – mood disorders, irritable bowel syndrome
c. CRF2 Peptide Antagonist (Urocortin) – cardiovascular
2. Research
a. sNRI – depression, stress, pain, and urinary incontinence
b. Glucose-dependent Insulin Secretagogues – Type II Diabetes
c. Ion Channel Blocker – chronic pain
3. Subject to regulatory review
a. Indiplon 5 & 10 mg capsules – insomnia
Neurocrine Biosciences has also entered into collaborative research with......

Join Now to view the rest of this term paper!
Members: Login to view this research paper.

Title: Neurocrine Biosciences, Inc.
Approximate Word Count: 302
Approximate Pages: 2 (250 words per double-spaced page)

With the Term Papers Lab Membership Pass, you get instant access to every essay on this site, including this essay on Neurocrine Biosciences, Inc., for as long as you remain a member.

Other essays sites charge almost $100 for a single term paper. At Term Papers Lab, you can get instant access to over 100,000 research papers for as little as $29.95!